Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Sep 28, 2020; 26(36): 5450-5462
Published online Sep 28, 2020. doi: 10.3748/wjg.v26.i36.5450
Table 1 Clinicopathological characteristics and treatment outcomes of all the patients and lesions treated with endoscopic submucosal dissection at our facilities between January 2005 and June 2016, n (%)
Pure DT (n = 1863)Pure UDT (n = 56)MT (n = 92)P value (Pure DT vs MT)
Age (yr), mean ± SD71.7 ± 8.566.0 ± 10.371.0 ± 9.1< 0.0001
Male1409 (75.6)30 (53.6)62 (67.4)0.0739
Location0.5385
Upper third340 (18.3)6 (10.7)14 (15.2)
Middle third536 (28.8)28 (50.0)31 (33.7)
Lower third987 (53.0)22 (39.3)47 (51.1)
Macroscopic type0.0002
Elevated759 (40.7)3 (5.4)18 (19.6)
Flat34 (1.83)01 (1.1)
Depressed1070 (57.4)53 (94.6)73 (79.4)
Tumor diameter (mm), mean ± SD16.1 ± 11.414.6 ± 9.624.4 ± 13.9< 0.0001
Depth< 0.0001
Mucosal1635 (87.8)45 (80.4)50 (54.4)
Submucosal228 (12.2)11 (19.6)42 (45.7)
Ulcerative findings150 (8.1)9 (16.1)18 (19.6)0.0001
Lympovascular invasion57 (3.1)4 (7.1)21 (22.8)< 0.0001
En bloc resection1853 (99.5)55 (98.2)92 (100)0.4811
R0 resection1835 (98.5)53 (94.6)81 (88.0)< 0.0001
Curative resection1686 (90.5)27 (48.2)35 (38.0)< 0.0001
Additional surgery97 (5.2)13 (23.2)36 (39.1)< 0.0001